New “21st Century Cures” Legislation: Speed and Ease vs Science

The 21st Century Cures Act was signed into law in December 2016. Praised by its advocates as a means of speeding drug development, the act covers several areas, but the provisions related to the US Food and Drug Administration (FDA) will be among the most problematic and potentially important. The F...

Full description

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 2017-02, Vol.317 (6), p.581-582
Main Authors: Kesselheim, Aaron S, Avorn, Jerry
Format: Article
Language:English
Subjects:
Budgets - legislation & jurisprudence
Clinical trials
Drug Approval - legislation & jurisprudence
Drug Industry - standards
Federal legislation
Financing, Government - legislation & jurisprudence
Health care
National Institutes of Health (U.S.) - economics
National Institutes of Health (U.S.) - legislation & jurisprudence
Politics
Research Support as Topic - economics
Research Support as Topic - legislation & jurisprudence
Science - legislation & jurisprudence
United States
United States Food and Drug Administration - legislation & jurisprudence
United States Food and Drug Administration - standards
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!